The Drug Hunter Speaker Series is an ongoing series of talks about drug discovery with the Drug Hunter team and guest experts in the field.
Each virtual event will have a presentation, interview, or conversation with guests, followed by audience Q&A and discussion.
Watch previous sessions on our Drug Hunter YouTube channel.
Topic: Recent Highlights in Drug Discovery: Q2/Q3 2022
Join us for a Drug Hunter webinar in which we'll cover interesting drug discovery highlights from Q2/3 of 2022, including interesting scientific gems from recent drug approvals, Molecules of the Month, industry conferences, and other industry developments.
Dennis started Drug Hunter because he felt science-focused drug discovery professionals were underserved by existing media outlets. Dennis started his career as a drug discovery scientist at a now publicly-listed biotech startup (RAPT), where he contributed to the discovery of a first-in-class phase II drug candidate for cancer immunotherapy which demonstrated efficacy in early patients. He later joined Genentech, a subsidiary of Roche, the largest pharmaceutical company in the world by revenue. He has been a chemistry and project team leader for several projects leading to patented and published chemical matter. He earned his PhD in Chemistry from Stanford University, MPhil by Research from the University of Cambridge on a Churchill Scholarship, and a dual BA/MS from Northwestern University as a Goldwater Scholar.
Drug Hunter helps drug discovery professionals save time, stay up-to-date, and discover ideas by curating factual information and providing a platform for industry experts to share knowledge. Our goal is to provide an inclusive platform that empowers, educates, and connects professional drug hunters, and celebrates the important work being done by the heroes in our industry.